$LLY - Eli Lilly's Zepbound Tops Novo Nordisk's Wegovy in Weight Loss in New Study -- WSJ
Zepbound Helped People Lose 20.2% of Body Weight After 72 Weeks, Versus 13.7% for Wegovy -- WSJ
Weight-Loss Results Are From Study Sponsored by Zepbound Maker Eli Lilly -- WSJ
From X
Disclaimer: The above content reflects only the author's opinion and does not represent any stance of CoinNX, nor does it constitute any investment advice related to CoinNX.